Interleukin-2 sublingual - Vitapharm

Drug Profile

Interleukin-2 sublingual - Vitapharm

Alternative Names: CSSR IL-2 - Vitapharm; CSSR sublingual IL-2 - Vitapharm

Latest Information Update: 06 Jul 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Vitapharm Technology Development
  • Class Adjuvants; Antineoplastics; Interleukins; Lymphokines
  • Mechanism of Action Interleukin 2 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Cancer; Rheumatoid arthritis

Most Recent Events

  • 06 Jul 2016 Interleukin-2 sublingual - Vitapharm is available for licensing -
  • 06 Jul 2016 Preclinical trials in Cancer in China (Sublingual)
  • 06 Jul 2016 Preclinical trials in Rheumatoid arthritis in China (Sublingual)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top